The U.S. procedure for federal drug approval is something of a mystery to many Americans. We believe independent testing is essential before health providers may sell medication to the public. We also agree it’s a good idea to do this centrally to maintain consistency. After that, things may seem a little blurred. So what exactly is the procedure and how does it work?
US Process for Federal Drug Approval Starts With Candidate Drug
US Process for Federal Drug Testing: Federal Drug Administration: U.S. Government Work
The drug manufacturer, or sponsor must successfully trial the drug through three stages under Federal Drug Administration supervision. These clinical trials are done on animals first, and then on three progressive random samples of people if they are successful.
Some people in each sample receive the drug, while the others receive a dummy, also called a placebo. However, neither administrators nor subjects know who received which. The goal is to eliminate expectations so the real results of tests show through. If everything checks out the process advances to the approval stage
Federal Drug Administration of Successfully Tested Drugs
The Federal Drug Administration (FDA) may wait a while to assess the longer term effects on people in the sample. However, the process for COVID-19 related drugs may complete faster in view of urgency. Once the FDA is satisfied with the test results, it reviews the information, and labeling for the drug, and may approve its use in the United States.
This completes the US process for federal drug approval in summary. In practice, there are details we jumped over for purposes of simplicity. There are now four COVID-19 drugs at the third stage of testing, which is Step 5 in the first FDA diagram. The Federal Drug administration has agreed to complete the administrative steps that follow, as fast as safely possible.
Related
Latest Info On Johnson & Johnson Serum
Scientists Self-Testing with Unproven Vaccine
Preview Image: Drug Discovery Cycle
